CHMP issues positive opinion for tablet formulation of Merck’s NOXAFIL® (posaconazole)
28 February 2014 | By Merck
Merck announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending approval of a new, investigational tablet formulation of NOXAFIL®...